129 related articles for article (PubMed ID: 24697311)
1. Novel derivatives of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with improved fluorescent and σ receptors binding properties.
Abate C; Niso M; Marottoli R; Riganti C; Ghigo D; Ferorelli S; Ossato G; Perrone R; Lacivita E; Lamb DC; Berardi F
J Med Chem; 2014 Apr; 57(8):3314-23. PubMed ID: 24697311
[TBL] [Abstract][Full Text] [Related]
2. Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).
Berardi F; Abate C; Ferorelli S; Uricchio V; Colabufo NA; Niso M; Perrone R
J Med Chem; 2009 Dec; 52(23):7817-28. PubMed ID: 19842660
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent derivatives of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) as a tool for uptake and cellular localization studies in pancreatic tumor cells.
Abate C; Hornick JR; Spitzer D; Hawkins WG; Niso M; Perrone R; Berardi F
J Med Chem; 2011 Aug; 54(16):5858-67. PubMed ID: 21744858
[TBL] [Abstract][Full Text] [Related]
4. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
5. 2-Aminopyridine derivatives as potential σ(2) receptor antagonists.
Abate C; Ferorelli S; Niso M; Lovicario C; Infantino V; Convertini P; Perrone R; Berardi F
ChemMedChem; 2012 Oct; 7(10):1847-57. PubMed ID: 22890883
[TBL] [Abstract][Full Text] [Related]
6. Arylamides hybrids of two high-affinity σ2 receptor ligands as tools for the development of PET radiotracers.
Abate C; Ferorelli S; Contino M; Marottoli R; Colabufo NA; Perrone R; Berardi F
Eur J Med Chem; 2011 Sep; 46(9):4733-41. PubMed ID: 21684636
[TBL] [Abstract][Full Text] [Related]
7. N-[omega-(Tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine are highly potent and selective sigma1 or sigma2 ligands.
Berardi F; Santoro S; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1998 Oct; 41(21):3940-7. PubMed ID: 9767631
[TBL] [Abstract][Full Text] [Related]
8. Analogues of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with added polar functionality and reduced lipophilicity for potential use as positron emission tomography radiotracers.
Abate C; Niso M; Lacivita E; Mosier PD; Toscano A; Perrone R
J Med Chem; 2011 Feb; 54(4):1022-32. PubMed ID: 21229979
[TBL] [Abstract][Full Text] [Related]
9. 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity.
Berardi F; Ferorelli S; Abate C; Colabufo NA; Contino M; Perrone R; Tortorella V
J Med Chem; 2004 Apr; 47(9):2308-17. PubMed ID: 15084129
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
Selivanova SV; Toscano A; Abate C; Berardi F; Müller A; Krämer SD; Schibli R; Ametamey SM
Nucl Med Biol; 2015 Apr; 42(4):399-405. PubMed ID: 25637276
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
12. Characterization of novel N,N'-disubstituted piperazines as sigma receptor ligands.
Zhang Y; Williams W; Torrence-Campbell C; Bowen WD; Rice KC
J Med Chem; 1998 Dec; 41(25):4950-7. PubMed ID: 9836612
[TBL] [Abstract][Full Text] [Related]
13. 1-Cyclohexylpiperazine and 3,3-dimethylpiperidine derivatives as sigma-1 (sigma1) and sigma-2 (sigma2) receptor ligands: a review.
Berardi F; Abate C; Ferorelli S; Colabufo NA; Perrone R
Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):205-19. PubMed ID: 20021355
[TBL] [Abstract][Full Text] [Related]
14. Development of sigma-1 (σ1) receptor fluorescent ligands as versatile tools to study σ1 receptors.
Abate C; Riganti C; Pati ML; Ghigo D; Berardi F; Mavlyutov T; Guo LW; Ruoho A
Eur J Med Chem; 2016 Jan; 108():577-585. PubMed ID: 26717207
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of bridged piperazines with sigma receptor affinity.
Weigl M; Wünsch B
Eur J Med Chem; 2007 Oct; 42(10):1247-62. PubMed ID: 17420073
[TBL] [Abstract][Full Text] [Related]
16. Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.
Pati ML; Hornick JR; Niso M; Berardi F; Spitzer D; Abate C; Hawkins W
BMC Cancer; 2017 Jan; 17(1):51. PubMed ID: 28086830
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands.
Moussa IA; Banister SD; Beinat C; Giboureau N; Reynolds AJ; Kassiou M
J Med Chem; 2010 Aug; 53(16):6228-39. PubMed ID: 20662542
[TBL] [Abstract][Full Text] [Related]
18. Chiral, nonracemic (piperazin-2-yl)methanol derivatives with sigma-receptor affinity.
Bedürftig S; Wünsch B
Bioorg Med Chem; 2004 Jun; 12(12):3299-311. PubMed ID: 15158798
[TBL] [Abstract][Full Text] [Related]
19. Novel and Selective Fluorescent σ2 -Receptor Ligand with a 3,4-Dihydroisoquinolin-1-one Scaffold: A Tool to Study σ2 Receptors in Living Cells.
Niso M; Riganti C; Pati ML; Ghigo D; Berardi F; Abate C
Chembiochem; 2015 May; 16(7):1078-83. PubMed ID: 25757101
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of naphthol- and carbazole-containing fluorescent sigma ligands as potential probes for receptor binding studies.
Ferorelli S; Abate C; Colabufo NA; Niso M; Inglese C; Berardi F; Perrone R
J Med Chem; 2007 Sep; 50(19):4648-55. PubMed ID: 17713896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]